---
{"dg-publish":true,"permalink":"/USMLE/GI/Colorectal cancer/"}
---

# Epidemiology
---
## Colorectal carcinogenesis pathways (molecular pathology) 
- Chromosomal instability pathway in colon cancer: The adenoma-carcinoma sequence is the progressive accumulation of mutations in <span style="background:rgba(240, 200, 0, 0.2)">[[USMLE/Pathology/Oncogenes\|oncogenes]] (e.g., KRAS) and tumor suppressor genes (e.g., APC, TP53)</span> that results in the slow transformation of adenomas into carcinomas.![L29403.jpg](/img/user/appendix/L29403.jpg)
>[!Mnemonic] 
>This follows the alphabet: <font color="#ffc000">A</font>PC -> <font color="#ffc000">K</font>RAS -> <font color="#ffc000">P</font>53
- ![Pasted image 20231216095151.png](/img/user/appendix/Pasted%20image%2020231216095151.png)
- Microsatellite instability pathway in colon cancer: due to methylation or mutations in mismatch repair genes (MMR genes, e.g., <span style="background:rgba(240, 200, 0, 0.2)">MLH1 or MSH2</span>), see [[USMLE/GI/Lynch syndrome\|Lynch syndrome]]
- <span style="background:rgba(240, 200, 0, 0.2)">COX-2 overexpression</span>
	- Associated with colorectal cancer
	- <span style="background:rgba(240, 200, 0, 0.2)">Possible protective effect of long-term use of aspirin and other [[USMLE/Pharmacology/Non-opioid analgesics\|NSAIDs]]</span>

# Etiology
---
## Risk factors for colorectal cancer
- Hereditary syndromes

| Syndrome                       | Gene Mutation | Colon Cancer Risk                                              | Other Associated Neoplasms                                                  |
| ------------------------------ | ------------- | -------------------------------------------------------------- | --------------------------------------------------------------------------- |
| Familial adenomatous polyposis | APC           | <span style="background:rgba(240, 200, 0, 0.2)">100%</span>    | Upper gastrointestinal, Thyroid, Desmoids/osteomas                          |
| [[USMLE/GI/Lynch syndrome\|Lynch syndrome]]             | MSH2/6, MLH1  | <span style="background:rgba(240, 200, 0, 0.2)">50%-80%</span> | <span style="background:rgba(240, 200, 0, 0.2)">Endometrial, Ovarian</span> |
| Peutz-Jeghers syndrome         | STK11         | 39%                                                            | Upper gastrointestinal, Pancreatic, Breast                                  |
- Associated conditions
	- <span style="background:rgba(240, 200, 0, 0.2)">Inflammatory bowel disease: chronic inflammation → hyperplasia → non-polypoid dysplasia → [[USMLE/Pathology/Cellular adaptations\|neoplasia]]</span>
		- [[USMLE/GI/Ulcerative colitis\|Ulcerative colitis]] 
		- [[USMLE/GI/Crohn disease\|Crohn disease]]

| Characteristics     | Colitis-associated                                                                                              | Sporadic                                   |
| ------------------- | --------------------------------------------------------------------------------------------------------------- | ------------------------------------------ |
| Age                 | Younger (age 40-55)                                                                                             | Older (age >60)                            |
| Origin of dysplasia | Flat (nonpolypoid) lesions                                                                                      | Polypoid lesions                           |
| Location            | Proximal > distal (particularly with CD)                                                                        | Distal > proximal                          |
| Tumors              | <span style="background:rgba(240, 200, 0, 0.2)">Multifocal</span>                                               | Singular                                   |
| Histology           | Mucinous and/or signet ring cells, <span style="background:rgba(240, 200, 0, 0.2)">Poorly differentiated</span> | Rarely mucinous, Well differentiated       |
| Mutations           | <span style="background:rgba(240, 200, 0, 0.2)">Early p53 mutation, Late APC gene mutation</span>               | Early APC gene mutation, Late p53 mutation |

# Pathophysiology


---
# Clinical features
## Right-sided colon carcinomas
- <span style="background:rgba(240, 200, 0, 0.2)">Large, bulky masses</span> that protrude into the colonic lumen due to the relatively large caliber of the ascending colon
- <span style="background:rgba(240, 200, 0, 0.2)">Occult bleeding or melena</span>
- Manifestations of [[USMLE/Blood/Iron deficiency anemia\|iron deficiency anemia]] (due to chronic bleeding)
## Left-sided colon carcinomas
- Often infiltrate the wall of the colon, encircling it and narrowing the lumen
- More likely to cause <span style="background:rgba(240, 200, 0, 0.2)">obstruction</span>
- <span style="background:rgba(240, 200, 0, 0.2)">Changes in bowel habits</span> (size, consistency, frequency) 
- Blood-streaked stools 
- <span style="background:rgba(240, 200, 0, 0.2)">Colicky abdominal pain</span> (due to obstruction)
	- Bowel obstruction occurs earlier in left-sided colon carcinomas <span style="background:rgba(240, 200, 0, 0.2)">because the distal colon has a smaller lumen </span>than the proximal colon and contains solid fecal matter.

---
# Diagnostics


---
# Treatment


---
